Jail Guard Opens Glass Partition So Inmate Dad Can Hold Baby, Emotional Moment Wins Hearts (WATCH Viral Video)

by

A viral video captured a heartwarming moment in a jail visitation room when an on-duty guard opened the standard glass partition. This compassionate gesture allowed an incarcerated father to step beyond physical restrictions and hold his baby in his arms. A tender, heartwarming moment inside a jail visitation room has captured widespread attention online, illustrating … Read more

Delhi Health Camp: CM Rekha Gupta Launches Free Mega Check-Up Drive In Haiderpur

by

Delhi CM Rekha Gupta inaugurated a free mega health check-up camp at Haiderpur Ayurvedic Hospital under the Seva Sankalp Abhiyan, offering residents health screenings, specialist consultations and guidance. Delhi’s chief minister Rekha Gupta has launched a free mega health check-up camp at an Ayurvedic hospital in Haiderpur under the ongoing campaign of ‘Seva Sankalp Abhiyan’. … Read more

AUS vs IND, Sydney ODI: Shreyas Iyer’s Incredible Catch Leaves Ashwin Impressed (WATCH)

by

Shreyas Iyer stunned fans with a breathtaking diving catch to dismiss Alex Carey in the 3rd ODI against Australia at SCG, earning praise from Ravichandran Ashwin. Iyer, however, suffered a left-side injury and had to leave the field. New Delhi [India], October 25 (ANI): Former spinner Ravichandran Ashwin lavished praise on India vice-captain Shreyas Iyer … Read more

The Paradise Advance Box Office Collection Day 1: Nani Film Sells 9.78 Lakh Tickets; Read On

by

The Paradise Advance Box Office Collection Day 1: Nani’s The Paradise has opened to massive pre-release interest, with advance bookings delivering a major milestone. The film has sold nearly 10 lakh tickets and secured one of 2026’s biggest opening-day pre-sales figures Nani’s The Paradise has arrived in theatres with a massive release across India. The … Read more

ARWR Stock: Goldman Sachs Resumes Coverage With $74 Target As Clinical Catalysts Near

by

Goldman sees biotech’s recent gains holding up despite macro pressures, supported by deal activity, clinical progress, and a more favorable regulatory backdrop. Goldman Analyst Andrea Newkirk highlighted acquisition activity and positive clinical catalysts as key supports for biotech’s recent performance. Earlier this month, Citi kept a Buy rating and $108 price target on Arrowhead, while … Read more

CSEAM online: SC slams Centre for delay, grants final opportunity

by

The Supreme Court granted the Centre a ‘final opportunity’ to report on measures to curb online Child Sexual Exploitation and Abuse Material (CSEAM), expressing concern over the government’s failure to file its response on the matter. SC Grants Centre Final Opportunity The Supreme Court on Thursday expressed concern over the Centre’s failure to file its … Read more

IRDM Shareholders Approve Acquisition By RKLB In $54-A-Share Deal — Iridium-Rocket Lab Merger Expected To Close By Mid-2027

by

Nearly 100% of votes cast backed the acquisition, bringing Rocket Lab closer to completing its planned purchase of Iridium. Iridium holders will receive $27 in cash plus Rocket Lab shares under the deal terms. RKLB shares were up 0.7% after hours, while IRDM stock slipped 0.29%. Stocktwits sentiment for IRDM remained ‘bullish,’ with ‘high’ message … Read more

AKAM Stock Soars 20% After-Hours — Akamai Lands $11.6B AI Cloud Deal With Anthropic

by

Akamai Technologies has signed a seven-year, $11.6 billion cloud infrastructure contract with AI research firm Anthropic. The initial seven-year agreement locks in $11.6 billion for Akamai Cloud services, with options to scale up to $20 billion.  Akamai issued Anthropic stock warrants for up to roughly 5% of its common stock, with vesting tied to contract … Read more

ACAD Stock Clocks Worst Day In 2 Years After Alzheimer’s Psychosis Drug Misses Main Goal — Citi Cuts Drug’s Success Odds To 20%

by

Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update. In the mid-stage portion of the RADIANT program, patients on 60 mg once daily remlifanserin improved 12.6 points on a scale of hallucinations and delusions at week six, versus 10.4 points on placebo. A key … Read more